Lv4
442 积分 2023-09-30 加入
Dehydrozingerone alleviates pulmonary fibrosis via inhibition of inflammation and epithelial-mesenchymal transition by regulating the Wnt/β-catenin pathway
5天前
已完结
The pleiotropic effects of PCSK9 in cardiovascular diseases beyond cholesterol metabolism
8天前
已完结
Effects of PCSK9 inhibitors on cancer, diabetes, and cardiovascular diseases
8天前
已完结
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension
15天前
已完结
Interstitial Lung Disease
18天前
已完结
Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
18天前
已完结
Impairment of the NKT–STAT1–CXCL9 Axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Caused by Lung Fibrosis
1个月前
已完结
Immune Checkpoint Inhibitor–Induced Cardiotoxicity
1个月前
已完结
Candidemia Following Severe COVID‐19 in Hospitalised and Critical Ill Patients: A Systematic Review and Meta‐Analysis
1个月前
已完结
Factors Affecting Mortality in Critically Ill Patients With Tuberculosis: A Systematic Review and Meta-Analysis
1个月前
已完结
皖公网安备34019202002308
